Children with epilepsy children with "life -saving medicine" is approved for import. Parents: Recently, you can buy from domestic hospitals
Author:Mengye News Time:2022.08.15
Elephant reporter Zhao Dan/Wen Tu
"I am worried that I should find clotca everywhere. I can prescribe medicine from the hospital in the past few days. I am particularly happy." On August 15th, I had been referred to as "drug trafficking" for the collection of chlorophasta parcels. Ms. Li, the mother of the patient, revealed that the chlorophara has made new progress in importing, and the family members of the children can buy through domestic hospitals recently.
According to Ms. Li, she gets solid news, and the family members of epilepsy can purchase chryphazla through the regular channels of the hospital. "Between the 15th and 25th, parents of the children can prescribe medicine from the hospital in Beijing. Everyone is glad and can finally buy it." Ms. Li said that she would take her child to Beijing to return to the clinic. Prepare some drugs, "Life will always be surprised after a hammer, and then a surprise doll can be prescribed from the hospital for the doll. Thank you for your efforts."
(Ms. Li takes a child to seek medical treatment)
Elephant News continued to follow up and reported that Ms. Li's son over 1 year old suffered from a rare epilepsy. Under the introduction of a doctor, she began to buy a drug chopcopichamine for the treatment of early childhood diseases. In many countries, chopcimockeys are approved and generally used for the treatment of epilepsy. In China, chlorophastin belongs to the second type of psychotropic drugs. It is strictly controlled and has not been approved for listing. In July 2021, Ms. Li was accused of "drug trafficking" for helping a buyer from receiving club chlorine. The police took the mandatory measures for the bail pending trial for "suspected smuggling, selling, and transportation of drugs." The purchaser is also a parent of a child. After 9 months of being detained, the court passed the application for the third bail pending trial for his family and lawyer.
(Ms. Li's medication time for the child)
In November 2021, the parent "Songsong Dad", a rare epilepsy in Guangzhou, wrote a letter with thousands of parents who was facing the risk of drugs to ask for help. channel. On June 29, 2022, the State Drug Administration issued a notice on the official website stating that in order to further improve the policies of drug supply and guarantee, to meet the people's demand for drug demand for urgent clinical urgently needed to be listed abroad and non -supplied in China, the country, the country, the country, and the country. The Health and Health Commission and the State Drug Administration have jointly issued the "Temporary Import Work Plan for Clinical Urgent Demonstrations" and "Caber Cabling Temporary Import Work Plan" (hereinafter referred to as the "Plan" and the "Caber Occupation Plan"), and announced the lead of the leader The list of 50 medical institutions used in imports and chine.
The "Cobra Occupation Plan" shows that the leading medical institutions need to meet multiple conditions: third -level hospitals; requiring to have epilepsy sub -specialties or related professional doctors to engage in epilepsy or children's epilepsy for more than 10 years; Standardize and emergency plans, establish clinical, pharmacy, and medical multidisciplinary diagnosis and treatment teams, and each prescription must not exceed one month.
The introduction of this policy will solve the dilemma of medical difficulties for the family of rare patients with epilepsy.
- END -
my country's new medicine research and development reached a record high, and how the innovative results have been achieved?
The 2021 review passed 47 innovative medicines--The research and development of new drugs hit a record high and how the innovation results areThe 2021 review passed the 47 innovative drugs, and hit a
Domestic innovation medicine evidence -based "milestone"!Zibutoni related studies were published in high scores of "Liuye Knife · Oncology"!
Recently, the BTK inhibitors independently developed by Baiji Divine Divine Phase III Sequoia study mid -term analysis data was published in the top international journal The Lancet Oncology magazin